Study confirms efficacy of molnupiravir against COVID in a real-life cohort antiviral treatment COVID molnupiravir SARSCoV2 wileymicrobio UniSassari
By Dr. Priyom Bose, Ph.D.Jul 26 2022Reviewed by Benedette Cuffari, M.Sc. Since the onset of the coronavirus disease 2019 pandemic caused by the severe acute respiratory syndrome coronavirus 2 , over 6.38 million deaths and 572 million infections have been reported.
Background Some of the common symptoms associated with COVID-19 include cough, fever, gastrointestinal disorders, dyspnea, headache, as well as loss of smell and taste. In some cases, individuals who experience severe COVID-19 may suffer life-threatening systemic inflammation, multiorgan dysfunction, and respiratory failure.
One of the key advantages of molnupiravir for the treatment of COVID-19 is that it can be easily administered at home. Other COVID-19 therapeutics, such as monoclonal antibodies and remdesivir, require hospital settings to be administered. The study cohort included adult participants diagnosed with COVID-19, which was confirmed by the reverse transcription-polymerase chain reaction assay. These patients were subjected to a five-day treatment course with molnupiravir according to the Italian Agency for Drugs guidelines.
During follow-up, 10.4% of participants exhibited disease progression. Notably, neurodegenerative disorders were associated with an increased risk of COVID-19 progression.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Scientists explore COVID-19-associated pulmonary aspergillosisResearchers computationally investigated the causes of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA).
Consulte Mais informação »
Scientists identify papain-like protease inhibitor against COVID-19In a new study, researchers identified a papain-like protease inhibitor for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.
Consulte Mais informação »
Live news updates: Adidas cuts outlook again over China Covid curbs and potential consumer slowdown\n\t\t\tExpert insights, analysis and smart data help you cut through the noise to spot trends,\n\t\t\trisks and opportunities.\n\t\t\n\t\tJoin over 300,000 Finance professionals who already subscribe to the FT.
Consulte Mais informação »
Insolvency Service uses new UK powers to ban Covid loan fraudsters\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
Consulte Mais informação »
Man with no health issues died from Covid days after 21st birthdayCameron Day tragically died from the virus despite having no underlying health issues
Consulte Mais informação »